Institutional members access full text with Ovid®

Share this article on:

Neurodevelopmental Outcome at 2 Years in Offspring of Women Randomised to Metformin or Insulin Treatment for Gestational Diabetes

Wouldes, Trecia A.; Battin, Malcolm; Coat, Suzette; Rush, Elaine C.; Hague, William M.; Rowan, Janet A.

Obstetrical & Gynecological Survey: March 2017 - Volume 72 - Issue 3 - p 149–151
doi: 10.1097/01.ogx.0000513223.74378.ed
Obstetrics: Medical Complications of Pregnancy

(Abstracted from Arch Dis Child Fetal Neonatal Ed 2016;101:F488–F493)

Gestational diabetes mellitus (GDM) is a common complication of pregnancy and is associated with deficits in motor, social, or linguistic development in offspring. Diet modification and insulin, which does not cross the placenta, have been the mainstay of treatment for GDM.

Department of Psychological Medicine, Faculty of Medical and Health Sciences (T.A.W.); New Born Services, Auckland City Hospital (M.B.), Auckland, New Zealand; Robinson Research Institute, The University of Adelaide, North Adelaide, South Australia (S.C.); Centre for Child Health Research, Auckland University of Technology, Auckland, New Zealand (E.C.R.); Department of Obstetrics, Women and Children’s Hospital, University of Adelaide, North Adelaide, South Australia (W.M.H.); and Department of Obstetrics, National Women’s Health, Auckland City Hospital, Auckland, New Zealand (J.A.R.)

Topics: Gestational diabetes mellitus, insulin, metformin, neurodevelopment.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.